Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
red blood cells (1 trial)
s303 red blood cells (1 trial)
beta-Thalassemia (Phase 3)
Thalassemia (Phase 3)
Trials (1 total)
Trial APIs (2 total)